Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis
- 30 April 1994
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 33 (3-4) , 331-334
- https://doi.org/10.1016/0028-3908(94)90062-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administrationEuropean Journal of Pharmacology, 1993
- Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis StudyJournal of Neurochemistry, 1993
- Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPATNeuropharmacology, 1992
- Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 1992
- Effect of antidepressant drugs on monoamine synthesis in brain in vivoNeuropharmacology, 1992
- Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPATNeuropharmacology, 1990
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- Modifications of the Serotonin System by Antidepressant TreatmentsJournal of Clinical Psychopharmacology, 1987
- Kinetics of citalopram in test animals; drug exposure in safety studiesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting propertiesEuropean Journal of Pharmacology, 1977